COVID-19 vaccines developed to assist Germany and the WHO prolong COVID-19

“The possibility should be looked into that the immune response to the virus itself may be impaired if the infecting virus damages, more or less selectively the cells responding to the viral antigens. If this proves to be the case, virus-induced immunodepression might conceivably be highly instrumental in prolonging certain virus infections, such as murine leukemia, hepatitis, … ” WHO, From the Bulletin of the World Health Organization, Volume 47, p.259, 1972, Recommendations (3)

The WHO / UN essentially directed virologists to develop ways to impair natural immune responses and prolong virus infections.

COVID-19 vaccines were developed to do just that – prolong SARS-CoV-2 infections. At least 2 vaccines were developed for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) based on a modified vaccinia virus.

“We developed two COVID-19 vaccines based on modified vaccinia virus Ankara (MVA) vectors expressing the entire SARS-CoV-2 spike (S) protein (MVA-CoV2-S)”  Spain virologist Mariano Esteban, from Madrid’s National Biotechnology Center, and by Felipe García, from the Clínic Hospital in Barcelona.

Spain’s experimental COVID-19 vaccines are based on genetic language, RNA, as are Moderna and Germany’s Pfizer-BioNtech vaccines. These vaccines introduce a genetic formula with instructions for human cells to produce the S proteins the novel coronavirus needs and uses to gain entry to our cells and once inside, the virus is free to replicate, making us sick.

The vaccinia virus “function by restricting the production of IFN by blocking the signaling pathways leading to transcription of IFN genes, stopping IFNs binding to their receptors, blocking IFN-induced signal transduction leading to expression of interferon-stimulated genes (ISGs), or inhibiting the antiviral activity of ISG products. – Geoffrey L Smith, University of Cambridge January 2018

Immunological research provides evidence that COVID-19 mRNA vaccines manufactured based on a modified vaccinia virus increases infection:

“Ferrets vaccinated with a modified vaccinia virus Ankara (MVA) vaccine expressing full-length S protein had increased infection and hepatitis following challenge71,72. Antibodies to S protein were reported to induce acute lung injury in experimentally infected macaques on the basis of histological examination.”

Leave a Reply